We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

1 hedge funds and large institutions have $3.27K invested in Taro Pharmaceutical Industries Ltd. in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $3.27K → $3.27K ($0)

67% less funds holding

Funds holding: 3 → 1 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MPWT
1
MassMutual Private Wealth & Trust
Connecticut
$3.27K – – –

TARO Hedge Fund Activity: Q1 2025 in Review

1 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q1 2025, worth a combined $3.27K — unchanged from a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of TARO and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

  • 1 institutional investor held Taro Pharmaceutical Industries Ltd. (TARO) as of Q1 2025, down from 3 in Q4 2024.
  • Funds reported $3.27K of Taro Pharmaceutical Industries Ltd. stock for Q1 2025, unchanged quarter-over-quarter.
  • 0 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q1 2025 and 2 closed out, a net change of -2 holders.

Based on aggregated 13F filings for Q1 2025.